Osaic Holdings
PHAT icon

Osaic Holdings’s Phathom Pharmaceuticals PHAT Stock Holding History

Osaic Holdings’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$16.4K Sell
2,235
-46
-2% -$434 ﹤0.01% 6321
2026
Q2 		$24.7K Sell
2,281
-23
-1% -$262 ﹤0.01% 6011
2026
Q1 		$25.6K Sell
2,304
-4,146
-64% -$52.4K ﹤0.01% 5705
2025
Q4 		$107K Sell
6,450
-4,502
-41% -$64.3K ﹤0.01% 4648
2025
Q3 		$130K Sell
10,952
-298
-3% -$3.08K ﹤0.01% 4570
2025
Q2 		$108K Hold
11,250
– – ﹤0.01% 4448
2025
Q1 		$70.5K Buy
11,250
+7,958
+242% +$48.3K ﹤0.01% 4452
2024
Q4 		$26.7K Buy
3,292
+2,277
+224% +$28.2K ﹤0.01% 5133
2024
Q3 		$18.4K Sell
1,015
-1,200
-54% -$16.8K ﹤0.01% 5436
2024
Q2 		$22.8K Buy
2,215
+1,985
+863% +$20.4K ﹤0.01% 5255
2024
Q1 		$2.44K Sell
230
-49
-18% -$416 ﹤0.01% 6393
2023
Q4 		$2.54K Sell
279
-2,434
-90% -$21K ﹤0.01% 6448
2023
Q3 		$28.1K Sell
2,713
-1,538
-36% -$21.1K ﹤0.01% 5368
2023
Q2 		$59.4K Buy
4,251
+4,100
+2,715% +$47.3K ﹤0.01% 4820
2023
Q1 		$1.08K Buy
151
+1
+0.7% +$9 ﹤0.01% 6928
2022
Q4 		$2K Sell
150
-400
-73% -$4.12K ﹤0.01% 6691
2022
Q3 		$6K Sell
550
-12,011
-96% -$114K ﹤0.01% 6289
2022
Q2 		$106K Sell
12,561
-35,854
-74% -$369K ﹤0.01% 4380
2022
Q1 		$659K Buy
48,415
+42,747
+754% +$691K ﹤0.01% 2958
2021
Q4 		$112K Buy
5,668
+3,592
+173% +$84.5K ﹤0.01% 4503
2021
Q3 		$67K Buy
2,076
+853
+70% +$28.3K ﹤0.01% 4879
2021
Q2 		$41K Hold
1,223
– – ﹤0.01% 5191
2021
Q1 		$46K Hold
1,223
– – ﹤0.01% 4937
2020
Q4 		$41K Hold
1,223
– – ﹤0.01% 4697
2020
Q3 		$45K Buy
1,223
+473
+63% +$16.4K ﹤0.01% 4376
2020
Q2 		$25K Buy
+750
New +$28.8K ﹤0.01% 4666

Other funds holding PHAT

Medicxi Ventures Management
Medicxi Ventures Management St. Helier, Jersey $127M AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Carlyle Group
Carlyle Group Washington, District of Columbia $8.36B AUM 14.46% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Catalys Pacific
Catalys Pacific Tokyo, Japan $210M AUM 33.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Osaic Holdings's PHAT Position: Q3 2026 in Review

Osaic Holdings reduced its Phathom Pharmaceuticals (PHAT) stake by 2% in Q3 2026, selling an estimated $434 and leaving 2,235 shares worth $16.4K. The position accounts for ﹤0.01% of the portfolio, ranked #6321.

Osaic Holdings first reported a position in PHAT in Q2 2020 and has held it in 26 quarters since. The position peaked at $659K in Q1 2022. 109 funds tracked by Wall St. Rank hold PHAT as of Q3 2026.

  • Osaic Holdings held 2,235 shares of Phathom Pharmaceuticals worth $16.4K as of Q3 2026.
  • Osaic Holdings sold 46 Phathom Pharmaceuticals shares in Q3 2026, an estimated $434.
  • Phathom Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #6321 holding.
  • Osaic Holdings first reported a position in Phathom Pharmaceuticals in Q2 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Phathom Pharmaceuticals position peaked at $659K in Q1 2022.
  • 109 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q3 2026.

Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.